Expression of DNA mismatch repair proteins and MSH2 polymorphisms in nonmelanoma skin cancers of organ transplant recipients

British Journal of Dermatology

Volumn 162, Issue 4, 2010, Pages 732-742

  Perrett, C M ^a,b   Harwood, C A ^a   McGregor, J M ^a   Warwick, J ^a   Cerio, R ^a   Karran, P ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Azathioprine; Mismatch repair; MSH2 polymorphism; Nonmelanoma skin cancer; Organ transplant recipient

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; MISMATCH REPAIR PROTEIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PROTEIN MLH1; PROTEIN MSH2; IMMUNOSUPPRESSIVE AGENT; MLH1 PROTEIN, HUMAN; MSH2 PROTEIN, HUMAN; NUCLEAR PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TUMOR MARKER;

ADULT; ARTICLE; CONTROLLED STUDY; EXON; FEMALE; GENOTYPE; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENCE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; MUTATION RATE; MUTATIONAL ANALYSIS; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN CANCER; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA; BASE MISPAIRING; GENETIC POLYMORPHISM; GENETICS; METABOLISM; MIDDLE AGED; SKIN TUMOR;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AZATHIOPRINE; BASE PAIR MISMATCH; CARCINOMA, SQUAMOUS CELL; DNA MISMATCH REPAIR; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; NUCLEAR PROTEINS; ORGAN TRANSPLANTATION; POLYMORPHISM, GENETIC; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 77949834940     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2009.09550.x     Document Type: Article

References (41)

1. Lynch HT, de la Chapelle A. Genetic susceptibility to non-polyposis colorectal cancer. J Med Genet 1999 36 : 801 818.
2. Borresen AL, Lothe RA, Meling GI et al. Somatic mutations in the hMSH2 gene in microsatellite unstable colorectal carcinomas. Hum Mol Genet 1995 4 : 2065 2072.
3. Herman JG, Umar A, Polyak K et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci USA 1998 95 : 6870 6875.
4. Veigl ML, Kasturi L, Olechnowicz J et al. Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers. Proc Natl Acad Sci USA 1998 95 : 8698 8702.
5. Karran P. Microsatellite instability and DNA mismatch repair in human cancer. Semin Cancer Biol 1996 7 : 15 24.
6. Karran P, Bignami M. DNA damage tolerance, mismatch repair and genome instability. Bioessays 1994 16 : 833 839.
7. Aquilina G, Giammarioli AM, Zijno A et al. Tolerance to O6-methylguanine and 6-thioguanine cytotoxic effects: a cross-resistant phenotype in N-methylnitrosourea-resistant Chinese hamster ovary cells. Cancer Res 1990 50 : 4248 4253.
8. Nara K, Nagashima F, Yasui A. Highly elevated ultraviolet-induced mutation frequency in isolated Chinese hamster cell lines defective in nucleotide excision repair and mismatch repair proteins. Cancer Res 2001 61 : 50 2.
9. Meira LB, Cheo DL, Reis AM et al. Mice defective in the mismatch repair gene Msh2 show increased predisposition to UVB radiation-induced skin cancer. DNA Repair (Amst) 2002 1 : 929 934.
10. Karran P, Offman J, Bignami M. Human mismatch repair, drug-induced DNA damage, and secondary cancer. Biochimie 2003 85 : 1149 1160.
11. Offman J, Opelz G, Doehler B et al. Defective DNA mismatch repair in acute myeloid leukemia/myelodysplastic syndrome after organ transplantation. Blood 2004 104 : 822 828.
12. O'Donovan P, Perrett CM, Zhang X et al. Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science 2005 309 : 1871 1874.
13. Harwood CA, Swale VJ, Bataille VA et al. An association between sebaceous carcinoma and microsatellite instability in immunosuppressed organ transplant recipients. J Invest Dermatol 2001 116 : 246 253.
14. Lowsky R, DeCoteau JF, Reitmair AH et al. Defects of the mismatch repair gene MSH2 are implicated in the development of murine and human lymphoblastic lymphomas and are associated with the aberrant expression of rhombotin-2 (Lmo-2) and Tal-1 (SCL). Blood 1997 89 : 2276 2282.
15. Marra G, D'Atri S, Yan H et al. Phenotypic analysis of hMSH2 mutations in mouse cells carrying human chromosomes. Cancer Res 2001 61 : 7719 7721.
16. Worrillow LJ, Travis LB, Smith AG et al. An intron splice acceptor polymorphism in hMSH2 and risk of leukemia after treatment with chemotherapeutic alkylating agents. Clin Cancer Res 2003 9 : 3012 3020.
17. Paz-y-Miño C, Pérez JC, Fiallo BF et al. A polymorphism in the hMSH2 gene (gIVS12-6T>C) associated with non-Hodgkin lymphomas. Cancer Genet Cytogenet 2002 133 : 29 33.
18. Brentnall TA, Rubin CE, Crispin DA et al. A germline substitution in the human MSH2 gene is associated with high-grade dysplasia and cancer in ulcerative colitis. Gastroenterology 1995 109 : 151 155.
19. Palicio M, Blanco I, Tórtola S et al. Intron splice acceptor site polymorphism in the hMSH2 gene in sporadic and familial colorectal cancer. Br J Cancer 2000 82 : 535 537.
20. Goessl C, Plaschke J, Pistorius S et al. An intronic germline transition in the HNPCC gene hMSH2 is associated with sporadic colorectal cancer. Eur J Cancer 1997 33 : 1869 1874.
21. Fishel R, Lescoe MK, Rao MR et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993 75 : 1027 1038.
22. Xia L, Shen W, Ritacca F et al. A truncated hMSH2 transcript occurs as a common variant in the population: implications for genetic diagnosis. Cancer Res 1996 56 : 2289 2292.
23. Bouwes Bavinck JN, Hardie DR, Green A et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. Transplantation 1996 61 : 715 721.
24. Thibodeau SN, French AJ, Roche PC et al. Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res 1996 56 : 4836 4840.
25. Dieumegard B, Grandjouan S, Sabourin JC et al. Extensive molecular screening for hereditary non-polyposis colorectal cancer. Br J Cancer 2000 82 : 871 880.
26. Stone JG, Robertson D, Houlston RS. Immunohistochemistry for MSH2 and MHL1: a method for identifying mismatch repair deficient colorectal cancer. J Clin Pathol 2001 54 : 484 487.
27. Marcus VA, Madlensky L, Gryfe R et al. Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors. Am J Surg Pathol 1999 23 : 1248 1255.
28. Dietmaier W, Wallinger S, Bocker T et al. Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. Cancer Res 1997 57 : 4749 4756.
29. Young LC, Listgarten J, Trotter MJ et al. Evidence that dysregulated DNA mismatch repair characterizes human nonmelanoma skin cancer. Br J Dermatol 2008 158 : 59 69.
30. Rass K, Gutwein P, Muller SM et al. Immunohistochemical analysis of DNA mismatch repair enzyme hMSH-2 in normal human skin and basal cell carcinomas. Histochem J 2000 32 : 93 7.
31. Entius MM, Keller JJ, Drillenburg P et al. Microsatellite instability and expression of hMLH-1 and hMSH-2 in sebaceous gland carcinomas as markers for Muir-Torre syndrome. Clin Cancer Res 2000 6 : 1784 1789.
32. Machin P, Catasus L, Pons C et al. Microsatellite instability and immunostaining for MSH-2 and MLH-1 in cutaneous and internal tumors from patients with the Muir-Torre syndrome. J Cutan Pathol 2002 29 : 415 420.
33. Mathiak M, Rutten A, Mangold E et al. Loss of DNA mismatch repair proteins in skin tumors from patients with Muir-Torre syndrome and MSH2 or MLH1 germline mutations: establishment of immunohistochemical analysis as a screening test. Am J Surg Pathol 2002 26 : 338 343.
34. Southey MC, Young MA, Whitty J et al. Molecular pathologic analysis enhances the diagnosis and management of Muir-Torre syndrome and gives insight into its underlying molecular pathogenesis. Am J Surg Pathol 2001 25 : 936 941.
35. Liang SB, Furihata M, Takeuchi T et al. Reduced human mismatch repair protein expression in the development of precancerous skin lesions to squamous cell carcinoma. Virchows Arch 2001 439 : 622 627.
36. Quinn AG, Healy E, Rehman I et al. Microsatellite instability in human non-melanoma and melanoma skin cancer. J Invest Dermatol 1995 104 : 309 312.
37. Claij N, te Riele H. Microsatellite instability in human cancer: a prognostic marker for chemotherapy? Exp Cell Res 1999 246 : 1 10.
38. Bellacosa A. Functional interactions and signaling properties of mammalian DNA mismatch repair proteins. Cell Death Differ 2001 8 : 1076 1092.
39. Rass K, Gutwein P, Welter C et al. DNA mismatch repair enzyme hMSH2 in malignant melanoma: increased immunoreactivity as compared to acquired melanocytic nevi and strong mRNA expression in melanoma cell lines. Histochem J 2001 33 : 459 467.
40. Wisgerhof HC, Hameetman L, Tensen CP et al. Azathioprine-induced microsatellite instability is not observed in skin carcinomas of organ transplant recipients. J Invest Dermatol 2009 129 : 1307 1309.
41. Hussein MR, Roggero E, Sudilovsky EC et al. Alterations of mismatch repair protein expression in benign melanocytic nevi, melanocytic dysplastic nevi, and cutaneous malignant melanomas. Am J Dermatopathol 2001 23 : 308 314.